Abstract
The annual CRN-International symposium, “Food Is Medicine: The Role of Nutrition in Extending Healthspan” sought to address the profound impact of dietary habits on health and healthy lifespan, as judicious nutritional choices can serve as a powerful tool for health promotion. A key question to consider with the “Food is Medicine (FIM)” movement is to what degree diet and nutrition regimes play a role in FIM efforts beyond treatment for morbidity and disease by contributing to resilience and extension of years people are healthy. A paradigm shift in healthcare policy and practice is necessary, recognizing nutrition and dietary interventions as foundational components of health care. Geography, cultural, and socioeconomic factors must be examined as integral parts of interventions that are sustainable and accessible to all, thereby democratizing health. Nutrition, including food, beverages, and dietary/food supplements, serves as a cornerstone of preventive medicine. Integration of nutritional strategies into the healthcare system is urgently needed so they are considered alongside medications, procedures, and tests, particularly for prevention and health promotion. There is a need for increased awareness and education about healthy dietary habits combined with policy changes that encourage such habits, contributing to an improved healthspan and quality of life.
Keywords: Food is medicine (FIM), Healthspan, Nutrition policy, Dietary supplements, Functional foods
Introduction
The importance of nutrition has evolved far beyond the traditional understanding of simply fueling the body or preventing overt nutrient deficiency. Today, optimal nutrition is increasingly recognized as a cornerstone of health, wellness, health promotion, and disease prevention. The World Health Organization (WHO) has focused public and scientific attention on the importance of a holistic strategy of encouraging healthful activities and discouraging socioenvironmental insults that undermine longevity [1]. Within this paradigm is nutritional optimization, a role for choiceful nutrition that builds resiliency and prevents or minimizes the detrimental outcomes associated with diseases, especially later in life. The philosophy of "Food is Medicine (FIM)" or Food First strategies encapsulate this paradigm shift, reflecting the concept that the food we consume has the power to not only sustain life but also to heal, protect, and enhance our physical and mental well-being prior to the need for allopathic medicinal intervention [2]. This aligns with a growing body of scientific research on resiliency underscores the profound impact of diet on a wide range of health outcomes, from chronic disease management to cognitive function and immune support. Well-intentioned socioeconomic or geopolitical constructs have often pitted nutrition and modern medicine against one another to extend our healthy lifespan, when evidence for the two working in harmony is clear. These proceedings capture recent advances highlighting the interwoven role played by nutrition in maintaining optimal longevity while underscoring the value that sound nutrition plays in rebounding from injury. Utilizing single ingredients as case examples, good nutrition is critical to support the functionality of musculoskeletal, hematopoietic, and immune systems, primary keys to extending quality of life, and warding off harm.
A crucial aspect of optimal nutrition is ensuring adequate protein intake. Protein is vital for muscle repair but also immune function, enzyme production, and hormone regulation. Inadequate protein intake can lead to a variety of health issues, including muscle wasting, weakened immunity, and slower recovery from illness or injury. It is particularly important as we age when the body’s ability to digest, absorb and synthesize protein decreases, leading to an increased need for dietary protein [3]. Less known, protein plays a significant role in stabilizing blood sugar levels and maintaining satiety, which helps prevent overeating and reduces the risk of obesity-related diseases [4]. Another vital nutrient that plays an essential role in maintaining optimal health is vitamin D, primarily synthesized by the body through exposure to sunlight but supplementation is often critical in situations where sunlight is limited. Adequate vitamin D intake is crucial for calcium utilization and bone health, a healthy immune response and vitamin D deficiency is linked to a range of health problems including an increased risk of chronic diseases such as cardiovascular disease, diabetes, and autoimmune conditions [5]. In addition to macronutrients and vitamins, botanicals and phytochemicals also play a significant role in promoting health. Phytochemicals—bioactive compounds found in plants—can be powerful antioxidants, anti-inflammatory agents, and immune modulators [6, 7]. Integrating these botanicals into daily nutrition provides an additional layer of support for the body’s natural defenses, highlighting the powerful synergy between plant-based nutrients and management of overall health.
The idea of FIM goes beyond preventing malnutrition or addressing dietary insufficiencies. It suggests that the strategic use of foods can assist conventional medicine with its aim of preventing, treating, and even reversing certain health conditions. As more individuals turn to diet as a proactive approach to health, medical professionals, researchers, and policymakers are increasingly advocating for nutrition as an essential tool in both chronic disease management and preventive healthcare.
This manuscript summarizes the outcome of the 2024 CRN-I symposium “Food is Medicine: The Role of Nutrition in Extending Healthspan”, exploring the intersection of optimal nutrition and the emerging concept of FIM. By examining scientific evidence and real-world applications, this symposium sought to provide a comprehensive understanding of how nutrition can serve as a powerful, accessible tool in promoting health and preventing illness. The authors highlight robust scientific evidence for the benefits of healthy nutrition on resilience and quality of life. The growing body of peer-reviewed FIM literature attests to the veracity of the claims without the need for traditional clinical trials as required for synthetic or iatrogenic compounds. As we continue to uncover the remarkable benefits of food, it becomes clear that optimal nutrition is not just a lifestyle choice but a vital component of modern healthcare.
Food is medicine: the role of nutrition in extending healthspan—OVERVIEW
Initially a philosophy acknowledging the connection between food and well-being, FIM has evolved into a set of programs and initiatives aimed at shaping public policy and the environment to improve the accessibility to, and sustainability of, nutritious foods. The concept that food—in all its forms—can effectively maintain health, prevent, manage, and/or treat specific conditions—is in accord with the modern and holistic view of nutrition. No longer exclusively applied for the prevention of overt nutrient deficiency, the field of nutrition has expanded to impact chronic disease risk, resilience and healthspan. Evidence continues to emerge demonstrating how various nutrition interventions, including dietary patterns, such as the Mediterranean diet, replete with micronutrients and bioactive substances, can impact the body’s ability to cope with physiological stress, slow the pace of acing and delay the onset of age-related functional decline.
According to the World Health Organization (WHO), health promotion, “…is the process of enabling people to increase control over, and to improve their health” [8]. The manner in which diet and nutrition promote health can be measured or demonstrated through intrinsic capacity (IC) or resilience. IC is defined by the WHO as, “…all the mental and physical capacities that a person can draw on and includes their ability to walk, think, see, hear and remember” [9], while the National Institutes of Health (NIH) defines resilience as, “…a system's capacity to recover, grow, adapt, or resist perturbation from a challenge or stressor…”[10]. The terms are somewhat synonymous; both are measurable, and both determine a person’s (or population’s) functional trajectory over time. In the context of healthspan, the greater the IC (or resilience), the longer the healthspan—the amount of time a person is healthy, free from chronic disease and disability, and enjoying a good quality of life.
It can be argued that the modern purpose of diet and nutrition is to equip the body to be more resilient, or enhance IC, and extend healthspan (and avoid disease in the process). The various domains of IC (Cognition, Locomotion, Psychological, Vitality, Sensory) [11] can all be impacted through nutrition and/or lifestyle interventions. The ability to maintain IC or resilience with age is in turn impacted by exposure to various common physiologic, metabolic, environmental, psycho/social, and dietary stressors (Table 1). The degree, frequency, duration, etc. of exposure to common stressors, including smoking (oxidative stress), sun exposure, alcohol consumption, being sedentary, infection, sleep deprivation, and others, negatively impacts organ and tissue function [12]. Nutrition interventions may exacerbate or protect against stress-induced cellular, tissue, and organ damage, ultimately impacting function in the form of IC or resilience outcomes.
Table 1.
Examples of nutrition intervention studies with resilience outcomes*
| Intervention | Stressor | Outcome(s) | Reference |
|---|---|---|---|
| Nicotinamide riboside supplementation | Inflammaging | Reduction in proinflammatory markers vs. Placebo | Elhassan et al. 2019 |
| Lutein supplementation | Computer monitor (blue light) exposure | Improved visual acuity & contrast sensitivity vs. Placebo | Ma et al. 2009 |
| β-alanine supplementation | 24 h simulated Sustained Military Operations | Maintenance of performance indicators (physical, reaction time, subjective soreness & fatigue) vs. Placebo | Varanoske et al. 2018 |
| Vitamin D supplementation | Psychological stress procedure | Normal recovery from stress in the winter months vs. Placebo | Hansen et al. 2020 |
*The studies listed are intended to be examples of how resilience outcomes can be incorporated into study designs to assess the impact of nutrition interventions on healthspan; the studies themselves are small and can only be considered as pilot data. Further research in larger clinical trials are needed to confirm both efficacy and safety of these interventions
Examples of nutrition interventions improving resilience
Various examples exist in literature demonstrating a positive effect of a nutritional intervention on resilience in the face of a stressor. The following examples are intended to be illustrative of how resilience outcomes may be incorporated into intervention study designs to assess the impact of nutrition interventions on healthspan. While promising, these studies are relatively small in size and duration, limiting the generalizability of the findings. Larger clinical trials including diverse populations are necessary to validate these initial findings. Such trials tend to be both time and resource intensive, and thus ideally are the purview of governments (e.g. NIH, UKRI, EU) to fund. With the present situation for government funding of biomedical research in peril in the US, more creative and diverse approaches for funding may need to be considered going forward.
A classic example relates to the essential coenzyme, nicotinamide adenine dinucleotide (NAD). Known mostly for its role in electron transport and ATP production, the oxidized form, NAD + is also involved in a range of cellular and DNA repair processes. Both aging and exposure to metabolic stress disrupts NAD + metabolism and depresses NAD + cell and tissue levels. This has been demonstrated in animal models to result in increased oxidative stress, inflammation, and tissue dysfunction. In humans, it is linked to a range of mitochondrial disorders, including several neurodegenerative diseases [13]. Lifestyle modifications, including calorie restriction [14], moderate exercise [15], and supplementation with NAD + precursors (forms of vitamin B3) [16] can prevent or even reverse this metabolic stress-induced NAD + decline. Daily supplementation with 1000 mg of the NAD + precursor nicotinamide riboside (NR) for 21 days in a group of older men (70–80 yrs; BMI 20–30 kg/m2) resulted in a significant increase in whole blood NAD + levels and a reduction in age-associated inflammation (n = 6 for NR, n = 6 for Placebo) [17]. Similar findings of NR supplementation and reduction in proinflammatory factors are supported in several very small and short-term human trials with less than 50 participants [18–22]. As a next step large-scale and longer-term clinical trials are needed to establish clinical efficacy and safety to advance application of NAD + at the clinical and public health level.
Lutein is a xanthophyll carotenoid naturally present in yellow and green leafy vegetables and in high concentrations in the macula, the part of the retina responsible for the central field of vision. Both epidemiological and intervention studies have long demonstrated a role for dietary and supplemental lutein in the reduction of ocular disease risk, including age-related macular degeneration and cataract [23]. Its ability to absorb high-energy blue light and scavenge free radicals may explain lutein’s beneficial effects. More recent studies suggest that short-term supplementation with lutein may enhance resilience following ocular stress. In one such study, 37 young adults exposed to daily computer monitor use of more than 10 h per day over the previous two years were supplemented with lutein (lutein at (6 (n = 12) or 12 (n = 12) mg/day, respectively) or placebo (n = 12). Computer screens are known to emit light wavelengths between 400 and 490 nm—the same as high-energy blue light. The lutein groups experienced improvements in visual acuity and contrast sensitivity compared to the placebo group [24]. Results of this study suggest that raising lutein status via supplementation may help improve visual resilience when faced with the ocular stress of high-energy blue light in younger adults.
Carnosine (β-alanyl-l-histidine) is a histidine-containing dipeptide naturally present in mammalian skeletal muscle and is suggested to play a role in the regulation of anaerobic exercise by acting as an intracellular pH buffer, modulating energy metabolism, quenching free radicals and impacting calcium ion signaling [25]. Supplementation with the carnosine precursor β-alanine is known to elevate muscle carnosine levels or status. A recent study by Varanoske et al. [26] investigated the impact of b-alanine supplementation on resilience in 19 military soldiers. Male soldiers were supplemented with 12 g/day of β-alanine (n = 10) or placebo (n = 9) for two weeks prior to an intense 24 h Sustained Military Operations exercise. At three time points (0 h, 12 h, and 24 h), soldiers’ physical performance, visual reaction time, subjective feelings of soreness and fatigue, and inflammatory and endocrine markers were assessed. The placebo group reported significantly higher subjective feelings of soreness and fatigue (at 12 h), slower visual reaction time (at 24 h), more errors on reaction time testing and a longer 1 km run time vs. the β-alanine group. These findings of one small clinical trial suggest that β-alanine supplementation prior to the onset of a substantial physical stress may improve the resilience of the soldiers, rendering them better equipped to cope with the stress.
Vitamin D is known to exert health effects beyond bone, with both geographic and seasonal variation in sun exposure impacting status. In a recent study, investigators examined the effect of vitamin D supplementation on stress resilience in 86 adult patients from an inpatient treatment facility [27]. Before and after supplementation with 1600 IU/day vitamin D (n = 39) or placebo (n = 43) for 6 months, patients were subjected to an experimental psychological stress procedure (involving completion of cognitive tasks during exposure to aversive noise). Psychophysiological activity was measured at baseline, during stress exposure, and during recovery. Prior to supplementation, both groups’ baseline, stress, and recovery activity were the same. However, following supplementation, the vitamin D group recovered normally with improved vitamin D status, while the placebo group did not, with no change in vitamin D status. Interestingly, the pre-supplementation stress assessment was conducted in the spring months while the post-supplementation assessment was conducted in the winter months. The findings of this small clinical trial suggest that improving vitamin D status, particularly in the winter months when status tends to decline, may enhance the ability to cope with, in this case, psychological stress. Larger clinical trials are needed to validate these initial findings.
Incorporating supplements into the FIM discussion
The examples provided (See Table 1 for summary) suggest that nutrition interventions with micronutrients and bioactive compounds may positively impact resilience or IC. This fundamental notion that nutritional interventions may enhance resilience, promote health, and extend healthspan is a foundational aspect of FIM. To date, FIM initiatives and programs have been discussed and implemented in the context of foods—access to nutritious and health promoting whole foods and prepared foods. Yet, food components, including essential micronutrients and bioactive compounds, in addition to whole foods, can impact health. Thus, in so much as the above examples utilized dietary supplements as the intervention, it begs the question of whether dietary/food/health supplements should be part of the FIM dialogue, provided the necessary trials are conducted to validate these outcomes. However, it must be acknowledged that supplements—as the name indicates—are supplementary to, not a substitute for, a healthy diet. Whole food-based diets include components, bioactives and phytonutrients, many of which have yet to be identified in combinations and ratios unlikely to be replicated by supplement products. To the extent supplements have a part in the FIM dialogue, it’s one that is complimentary in nature. Indeed, of the markets worldwide that have established a formal legal framework for dietary/food/health supplements, the overwhelming majority consider them a category of food [28]. Furthermore, in established markets like the US, roughly 75% of the population reports using dietary supplements [29]. According to the US National Health and Nutrition Examination Survey (NHANES), the top two reasons Americans cite for using supplements is to improve overall health and maintain health [30]. With recent advances in nutrition science, policy, and food and supplement regulation, now is the time to consider whether and how supplements can be part of the FIM movement.
Food is medicine: past, present, and future
Past
FIM is an ancient concept that has been an important part of many traditions and cultures across the globe. The Papyrus Ebers from ancient Egypt, one of the oldest surviving medical documents, contains many references to the medicinal properties of food [31]. In the Americas, for indigenous populations, the connection of food to the earth imbued it with both spiritual and healing properties [32, 33]. For example, the “three sisters” staple foods (corn, beans, and squash), found in many areas across the continent, were thought to have medicinal properties beyond their role in basic sustenance [34, 35]. In the Indian subcontinent, ayurvedic medicine emerged, with food as a critical part. Ayurvedic medicine uses foods therapeutically to balance the three doshas, which are energies or life forces (vata, pitta, kapha) [36, 37]. Ayurvedic medicine also emphasizes diet as prevention [37].
The concept of FIM was prevalent in later periods as well. In the fifth century B.C., the ancient Greeks’ understanding is revealed by the famous quote by Hippocrates of Cos, considered the father of Western medicine: “Let food be thy medicine and medicine be thy food.” During this time in Greece and Rome, the belief was that optimal body function relied on four main fluids, or humors: blood, yellow bile (choler), black bile, and phlegm [38]. Similar to the Ayurvedic doshas, balance was vital. An imbalance in the humors was considered a cause of illness, and patients were advised to eat different foods to treat illness [38, 39]. Also, during this general timeframe (third century B.C.), the Chinese medical book Huang Di Nei Jing (The Yellow Emperor’s Book of Medicine) was created, which is considered a foundational source for traditional Chinese medicine. Like the Greco-Roman humors and the Ayurvedic doshas, this text emphasized the concept of balance, in this case between yin and yang, with five elements as central to health and well-being [40]. To maintain health, it specified that grains, meat, vegetables, and fruit should be consumed in the right proportions [40].
Present
Current FIM efforts reaffirm the ancient connection between food and health while incorporating modern scientific evidence. The concept is especially relevant given an aging population—the number of people aged 65 and older is expected to double by 2050 [41]. Although life expectancy is increasing, a significant number of those years are impacted by diet-related chronic diseases such as heart disease and diabetes. Thus, while lifespan (the number of years people live) has increased, healthspan (how many of those years people remain healthy and disease-free) has not [42]. FIM can be key in treating and preventing chronic disease as people age.
FIM programs are defined as the provision of healthy food resources to prevent, manage, or treat specific clinical conditions in coordination with the healthcare sector [43]. There are several different types of FIM programs, and although they have common elements, each is unique in terms of history, priority population served, and operationalization. Produce prescription programs are one type of program in which patients are referred by healthcare providers and receive economic incentives, usually in the form of electronic cards or paper vouchers, to redeem for fruits and vegetables at retail food outlets (grocery stores, farmers markets, mobile markets) [44]. There is some evidence, mainly from pre-post studies, that these programs can reduce HbA1c, BMI, and blood pressure [44]. Additional studies, including randomized controlled and comparative effectiveness trials are needed to fully assess the impact of these programs on health outcomes. Produce prescription programs are suitable for preventing disease among at-risk patients who can shop and prepare food independently. Medically tailored groceries are a prescribed selection of foods designed to address a specific diet-related diagnosis [44]. Some programs provide home delivery of the groceries to help improve access among patients with barriers to shopping; however, the patient must be capable of preparing food at home. Medically tailored meals are fully prepared meals delivered to a patient’s home, and a registered dietitian designs them to meet the specific dietary requirements of a patient living with one or more health conditions [44]. They can benefit patients who have difficulty shopping or preparing meals for themselves. All types of FIM programs typically include some form of nutrition education, such as one-on-one counseling or classes. Although research is ongoing, for all types of programs, the evidence is mounting for the effectiveness in improving food security, diet quality, health outcomes, and healthcare utilization and costs (reviewed in Mozaffarian et al. [44]).
Future
As FIM programs continue to grow and develop, especially as new policies are enacted to support them, it will be critical to ensure that they are feasibly and sustainably integrated into healthcare systems and fully accessible to patients who are most in need. To that end, there has been an increasing number of studies examining the implementation of these programs [45–50]. More is being learned about best practices for integrating them into a clinical workflow so that they do not overburden staff. Research to date suggests the importance of offering up-front support for clinics adopting these programs, standardizing some aspects of the programs but allowing some flexibility to integrate them into clinical workflows, and identifying policy opportunities to ensure the sustainability of the programs since clinics are unable to bear the costs [45–47, 49]. Implementation studies can also help document the barriers to participation that patients may face, which is critical to adapting the program design so that programs can better include patients with fewer resources and looser ties to healthcare systems. These studies will help ensure efficient, equitable, and sustainable implementation as we move forward into the future of FIM programs.
Meals that move you: the importance of protein-rich food for muscle mass and function with age
Maintaining an adequate quantity and quality of skeletal muscle is vital for metabolic health and functional independence with advancing age. This important tissue is constantly ‘turning over’ through the targeted degradation of old/damaged protein into its constituent amino acids, with new functional proteins synthesized in their place. Through its ability to stimulate muscle protein synthesis, which can be compromised with advancing age and/or inactivity [51], dietary protein represents an important nutritional factor to help mitigate the risk or severity of sarcopenia, which is defined as the loss of muscle mass and strength/function. For example, older adults consuming > / = 1.2 g/kg/d, which exceeds the current recommended dietary allowance (RDA) of 0.8 g/kg/d, was associated with a ~ 44% attenuation in lean body mass (including muscle) decline over 3 years compared to those consuming at or below the RDA [52]. Furthermore, a well-controlled prospective study demonstrated that older adults consuming the RDA experienced ~ 1.5% loss of thigh muscle cross-sectional area in just 3 months [53] which is equivalent to the expected 3-year loss reported by some [54]. Observational data have also revealed greater indices of upper and lower body strength as well as muscle quality (i.e., strength normalized to muscle CSA [cross-sectional area]) in older adults consuming > 1.2 g/kg/d protein as compared to those consuming below this level [55]. The impact of protein on functional strength measurements such as grip strength may be greater at older ages (i.e., > 65 years for women and > 75 years for men) [56]. Collectively, these observations have contributed to the growing call for increasing the recommended daily intake of protein for older adults to help mitigate age-related loss of muscle mass and function [57–59]. Despite recommendations that older adults should target ~ 1.0–1.2 g/kg/d, many community dwelling older adults consume below this level with up to ~ 57% not meeting a minimum of 1.0 g/kg/d in some cohorts [60].
While targeting a daily protein intake may be useful for older adults, physiologically, the muscle responds to the nutrients consumed within a 4-6 h postprandial period. It is clear that meal protein ingestion stimulates the synthesis of muscle proteins (including the force-generating myofibrillar proteins) in both young and older adults [61]. However, older adults require a greater meal protein intake to obtain a similar benefit as their younger counterparts (~ 0.4 g/kg vs ~ 0.25 g/kg, respectively) [62]. However, indiscriminately increasing meal size (i.e., both protein and energy) may not be advisable for all adults given the growing incidence of sarcopenic obesity [63], which itself can be counterproductive via its association with anabolic resistance to protein and exercise [64, 65]. Thus, when evaluating the typical daily protein distribution that is skewed towards the greatest meal protein in the evening [66], the first meal of the day after an overnight fast (i.e., negative muscle protein balance) may represent an ideal opportunity for protein supplementation or advocating older adults consume greater protein-containing foods. To this point, foods that have a higher protein:energy density arguably should be prioritized for older adults to ensure adequate intake of the anabolic essential amino acids (EAA) [67]. Importantly, the EAA leucine is known to be particularly anabolic for skeletal muscle due to its robust ability to activate the mechanistic target of rapamycin canonical signaling pathway, a process that is attenuated with age but can be reversed with higher dietary leucine intake [68–71].Thus, the general recommendations to optimize postprandial muscle protein synthesis are to consume an adequate quantity and quality of dietary protein at each meal of the day to counter any age-related anabolic resistance to help mitigate the risk of sarcopenia. Further, in addition to government recommendations (e.g. U.S. Department of Agriculture MyPlate) to consumed nutrient dense, lower fat foods, it has been argued that the density and bioavailability of EAA in food as well as factors related to processing (e.g. heat treatment) should be considered when identifying optimal food protein options to stimulate muscle anabolism with age [72]. While a focus on higher daily protein, especially from animal sources such as red meat, has been suggested to increase the risk of mortality from cancer or cardiovascular disease (CVD) [73, 74], recent analysis of the NHANES data do not support that usual protein intake per se or that of animal-origin specifically impact the risk for CVD or cancer [75]. Nevertheless, in addition to optimizing the anabolic potential of dietary protein (as discussed below), physical activity should be viewed as paramount to reducing the risk of CVD, cancer, and all-cause mortality and disease in addition to (or irrespective of) diet quality [76].
Skeletal muscle is a plastic tissue that is able to respond to physical stimuli or lack thereof. During muscle disuse (e.g. bed rest, limb immobilization) there is a characteristic loss of muscle mass, independent of age, that is underpinned by inactivity-induced anabolic resistance [77]. However, even more ‘benign’ forms of disuse, such as a low daily step count, are associated with an attenuated muscle protein synthetic response to dietary protein ingestion, which may underpin or exacerbate age-related anabolic resistance and muscle loss [78, 79]. It is therefore concerning that average daily step counts may decrease with age [80] and be associated with low muscle mass and function in older adults [81, 82]. However, lighter load but high effort resistance exercise is a potent countermeasure to low daily step counts that can completely offset inactivity-induced muscle loss and improve the muscle protein synthetic response to dietary protein [83]. This highlights the established role of resistance exercise to increase the utilization of dietary amino acids for new muscle protein synthesis regardless of age [84]. Moreover, merely performing a moderate intensity evening walk (~ 3500 extra steps per day) can increase the delivery of dietary amino acids to and muscle protein synthetic response of older skeletal muscle the following morning [85, 86], highlighting that even a suboptimal daily protein distribution may be improved by increased physical activity. Finally, we have recently demonstrated that reducing daily sedentary time through the utilization of exercise breaks (2 min of moderate walking or 15 sit-to-stand chair rises) every 30 min increases the utilization of dietary amino acids to build new muscle in otherwise healthy adults [87]. Thus, moving more and sitting less during the postprandial period may represent a feasible, cost-effective, and accessible lifestyle approach that improves the anabolic potential of any/all food (potentially irrespective of protein quality) to support optimal muscle mass and function across the life span (Fig. 1).
Fig. 1.
Dietary protein and physical activity recommendations to maintain optimal muscle mass and quality with age. RDA, recommended dietary allowance. Figure created with BioRender (Toronto, Canada)
The potential for dietary phytochemicals to boost healthspan: a critical evaluation
Healthspan
Healthspan is the period of life characterized by the absence of poor health (i.e., no type 2 diabetes, cardiovascular issues, chronic inflammation, impaired cognition, nor digestive problems) along with adept metabolic responses to meal challenges, resilience to stress, high vitality, and a healthy gut microbiota. Obesity, consumption of a poor diet, lack of exercise, and environmental factors lead to chronic conditions that can all shorten the healthspan. Healthy diets that are high in phytochemicals can help lower the risk of an early onset of chronic conditions. Research and advice in this area must be based on evidence, including human intervention studies, mechanistic studies, and epidemiology, but current advice is fragmented, and most countries do not have recommendations for phytochemical intake.
Classification, nomenclature, and amounts of dietary phytochemicals in foods
A description of the differences between phytochemicals, phytonutrients, bioactives, and (poly)phenols has been reported [88]. The latter includes phenolic acids, stilbenoids, isoflavones, flavonoids, and tannins. Other phytochemicals include carotenoids, phytosterols, alkaloids, and organosulfur compounds. Typical contents of phytochemicals in the diet of a person consuming 5 portions of fruit and vegetables per day with coffee and tea are 600–1000 mg (poly)phenols and 4–20 mg carotenoids based on composition data of raw foods. However, many phytochemicals are lost during processing. Indeed, almost all are absent from ultra-processed foods [89], and over-consumption of ultra-processed foods is a major dietary cause of adverse health outcomes, including negative effects on metabolic health [90]. After consumption of phytochemicals, metabolites appear in the blood with defined kinetics depending on the chemical structure of the parent compound. The gut microbiota plays an important role in the metabolism of many phytochemicals and often leads to the production of further bioactive compounds.
What are the mechanisms and evidence for the action of phytochemicals on healthspan?
Firstly, it is important to note that the property of being a chemical antioxidant does not imply any health effects. Although various tests have been reported in the literature, they are only useful for showing the total content of some phytochemicals in foods and beverages [91]. In addition, effects are likely to be subtle but important as they are exerted over a lifetime, since food is consumed every day. Multiple effects of phytochemicals have been proposed, but here we focus on the reported actions to lower the risk of type 2 diabetes, vascular dysfunction, and chronic inflammation, important parameters related to healthspan.
Effects of phytochemicals on blood sugar and insulin related to type 2 diabetes risk
Good metabolic health is characterized by well-regulated fasting blood glucose and insulin, low triglycerides and branched chain amino acids, insulin-responsive muscle, and a strong flow-mediated dilation (FMD) response. With a diet high in calories and ultra-processed foods, metabolic inflexibility develops, leading to increased ectopic fat, increased fasting blood glucose, lowered insulin sensitivity, elevated triglycerides and branched chain amino acids, together with an impaired FMD response. Phytochemicals can affect multiple steps in this progression, including inhibition of α-amylases [92] and of α-glucosidases [93] to lower postprandial blood glucose. The importance of this effect in lowering the risk of developing metabolic dysfunction is shown by acarbose, a drug that inhibits these enzymes but is not absorbed. Chronic acarbose administration decreased the incidence of diabetes by 36%, improved FMD, and lowered cardiovascular disease events [94]. Are phytochemical-containing supplements as effective as foods? Using the example of orange juice, several studies have examined the effects of whole orange juice or hesperidin supplements on metabolic outcomes in overweight volunteers or with metabolic syndrome in randomized controlled studies. Over 12 weeks, 500 ml of orange juice per day containing 120–160 mg hesperidin lowered HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) and fasting blood glucose [95, 96], whereas 250 ml did not [97]. A larger dose of hesperidin (1000 mg per day) alone also lowered HOMA-IR and fasting blood glucose [98]. Tea and coffee both contain high levels of phytochemicals. There is a dose-dependent reduction in risk of developing type 2 diabetes with both tea and coffee consumption in epidemiological studies [99–101], which is mostly not due to caffeine [102, 103]. A meta-analysis, with a total of ~ 200,000 participants, concluded that 4 cups of coffee per day gave a 35% reduction in the risk of type 2 diabetes [104]. Another meta-analysis, with a total of ~ 500,000 participants, demonstrated that the effect was dose-dependent, where each cup of coffee per day gave ~ 7% reduction in type 2 diabetes risk [105].
Effects of phytochemicals on vascular dysfunction related to lowered cardiovascular disease risk
Endothelial dysfunction is an early stage of cardiovascular disease, assessed by FMD. Many phytochemicals have been shown to have an effect on FMD and cardiovascular risk. As an example, a systematic review and meta-analysis of nine relevant studies on about 300 volunteers showed a strong chronic protective effect of anthocyanin-rich foods or extracts on fasting FMD [106]. The largest human intervention study to date on phytochemicals was on cocoa flavanols and cardiovascular risk. It involved > 21,000 healthy male and female volunteers (> 60 years old) given cocoa flavanols for 5 years in a randomized, placebo-controlled, double-blinded study. In compliant participants, there was a significant reduction of 15% in the total count of all cardiovascular events and a 39% reduction in deaths from cardiovascular disease [107].
Conclusions on phytochemicals and healthspan
Phytochemicals are absorbed from food, beverages, and supplements into the blood, often requiring the action of gut microbiota, and act by multiple mechanisms against conditions that lower healthspan. By targeting sugar spikes, energy metabolism, and nitric oxide signaling in the blood vessel walls, specific phytochemicals at sufficient doses in foods or supplements protect against the development of type 2 diabetes, vascular dysfunction, and chronic inflammation based on evidence from epidemiology, human interventions, and mechanistic studies when consumed habitually. Recommendations on individual phytochemicals are difficult to make, as epidemiological studies and most intervention studies are on phytochemical-rich foods and not on individual compounds. Often a higher dose of the pure compound is required to obtain the equivalent effect of a food in an intervention study, presumably because the presence of other phytochemicals and nutrients in the food leads to interactions and synergy between components.
Vitamin D: What did we learn from recent mega-trials, VITAL and DO-HEALTH?
Vitamin D deficiency remains prevalent in the population as a whole. Data suggest that children and younger adults present with vitamin D deficiency in about 50% of cases (25-hydroxyvitamin D [25(OH)D] levels < 20 ng/ml or < 50 nmol/l) [108]. The highest vitamin D deficiency prevalence, however, has been documented in older hip fracture patients, with about 80% being affected [109]. This is in part explained by the fact that ageing reduces skin production of vitamin D four-fold compared with younger adults [110]. An important role of vitamin D in overall health is supported by the presence of the specific vitamin D receptor in many organs, including the intestine, muscle, bone, brain, and the immune system [111].
While vitamin D plays an important role in bone health at any age [112], at older age, vitamin D deficiency contributes to the risk of sustaining fractures in two ways: (1) it impairs calcium metabolism causes secondary hyperparathyroidism and bone loss [112], (2) it causes muscle weakness and thereby promotes the risk of falling [113]. Consistently, daily vitamin D supplementation with 800 to 1000 IU was found to reduce fall [114] and fracture risk [115] in vulnerable older adults at risk of vitamin D deficiency. However, such benefits have not been confirmed in generally healthy and largely vitamin D replete middle-aged [116, 117] (VITAL) and older adults [118] (DO-HEALTH). Further, detrimental effects with an increase in falls and fractures were found with intermittent bolus dosing of vitamin D in monthly to yearly intervals (60,000 to 100,000 IU monthly, or 300,000 to 500,000 yearly) in vulnerable older adults [119]. The detrimental effects of vitamin D with intermittent bolus dosing have in part been explained by its triggering of countervailing factors that induce the degradation of vitamin D [119].
Two recent large clinical trials provide new insight on the effects of daily vitamin D supplementation in a dose of 2000 IU vitamin D on the immune system in generally healthy and largely not vitamin D deficient adults age 50 and older in the VITAL trial and age 70 and older in the DO-HEALTH trial. The European DO-HEALTH trial enrolled 2157 adults age 70 [118] and the US VITAL trial enrolled 25,871 adults [120]. Both trials were designed as partner trials. In VITAL among adults age 50 and older and over a 5-year treatment period, vitamin D supplementation reduced serum hs-CRP levels by 19% [121], reduced incidence of autoimmune diseases by 22% (31% if combined with omega-3 supplementation) [122], reduced incidence of advanced metastatic or fatal cancers by 17% [123] and reduced cancer mortality by 25% [120]. In DO-HEALTH among adults age 70 and older and over a 3-year intervention, findings showed an additive effect of vitamin D with omega-3 and a simple strength exercise program tested in an 8-arm study design to document individual and combined benefits of the interventions. The trial found that individuals who received a combination of 2000 IU/day of vitamin D3, 1 g of omega-3 s, and exercise (3*30 min a week) reduced their cancer risk by 61% [124], reduce their pre-frailty risk by 39% [125] and slowed their biological aging by on average 3 months [126].
Conclusion
The CRN-International Scientific Symposium explored the evolution of the FIM paradigm and examined current initiatives aimed at medical treatment, disease prevention, and health promotion. The potential of diet and nutrition to extend healthspan as part of FIM efforts is promising but for several nutrients lack evidence and safety data from large-scale clinical trials is missing. However, larger clinical trials exist for dietary regimes, including fruits and vegetables, protein, omega-3 and vitamin D. The distinguished expert presenters further considered the integration of specific dietary regimes and supplementation focused on health promotion and prevention into FIM programs and health policies for strategies that have been proven to be effective and safe in larger clinical trials,
Evidence-based solutions are of paramount importance for any FIM program, from a public health policy perspective, fortification and supplementation in low- and middle-income countries are currently crucial tools at the population level, particularly for specific life stages and vulnerable populations. However, data on dietary intake is often poor or non-existent, making it challenging to tailor interventions effectively. There is potential for "precision nutrition" in medically tailored meals, where dietary plans are customized to individual needs, potentially including supplementation. While evidence-based dietary supplements are already prescribed by healthcare professionals, they are typically excluded from healthcare coverage policies and should be considered for reimbursement, similar to medically tailored meals.
There is a need to reframe health promotion with a more comprehensive definition, incorporating the concept of resilience and using resilience-based study designs to demonstrate the effectiveness of interventions. Micronutrient deficiencies remain prevalent even in high-income countries and may be exacerbated by dietary transitions. FIM approaches should therefore include systematic monitoring and mitigation of micronutrient gaps alongside efforts to optimize overall dietary quality and food patterns. Additionally, there is a need for updated dietary guidelines, school meal programs with nutrition education, and a shift from a purely clinical focus to a broader, societal approach that emphasizes the social and cultural aspects of food. Family-based interventions should be considered as healthy habits are often learned within this context. Efforts should focus on making healthy eating fun and engaging, particularly for children, and on leveraging social media as an educational tool.
Integrating FIM principles into health policy requires a multi-faceted approach that addresses evidence-based supplementation, early intervention, health promotion, and social and cultural aspects of food. There is a need for continued research, particularly in the areas of food processing, health promotion, and the development of effective interventions that resonate with diverse populations.
Acknowledgements
This conference report summarizes the presentations and outcomes of the meeting entitled, “Food Is Medicine: The Role of Nutrition in Extending Healthspan” held on September 29, 2024, in Dresden, Germany. The event was organized and hosted by the Council for Responsible Nutrition-International. The opinions expressed herein, are those of the authors; this conference report is not a consensus statement, therefore, some authors may not agree with all the opinions expressed. The authors gratefully acknowledge Erin Storer for her significant work on document formatting, reference management, and editorial support in preparing this manuscript for publication. This is the fourteenth CRN-International conference report. Previous conference reports were published in Regulatory Toxicology and Pharmacology [127], and for the last twelve years in the European Journal of Nutrition [128–139].
Data availability
No new data were generated or analyzed in support of this symposium report. Data sharing is not applicable to this article.
Declarations
Conflict of interest
The event was organized and supported by the Council for Responsible Nutrition-International (CRN-I), an association representing dietary supplement and functional food manufacturers and ingredient suppliers. CRN receives support primarily from its industry membership. H. Bischoff-Ferrari, S Folta, D Moore, A Shao, G Williamson, and JC Griffiths had their travel expenses reimbursed by CRN-I. A Shao is an employee of ChromaDex, a CRN board member, and a former CRN employee. L Huber is an employee of CRN. D Marsman is a former chair of the board of directors for CRN-I. M Stout is an employee of Amway/Nutrilite and a CRN board member. JC Griffiths is a former employee of CRN. None of the authors declares any conflict of interest in providing their solely scientific opinion for this review.
References
- 1.WHO (2018) Essential nutrition actions: mainstreaming nutrition through the life course. WHO. https://www.who.int/publications/i/item/9789241513500
- 2.Yu Z, Ke L, Lu T, Li L, Gu H, Rao P (2024) Implementing a food-first strategy can transform preventive healthcare. npj Sci Food 8:57. 10.1038/s41538-024-00297-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Yuan S, Larsson SC (2023) Epidemiology of sarcopenia: prevalence, risk factors, and consequences. Metabolism 144:155533. 10.1016/j.metabol.2023.155533 [DOI] [PubMed] [Google Scholar]
- 4.Leidy H, Clifton P, Astrup A, Wycherley T, Westerterp-Plantenga M, Luscombe-Marsh N, Woods S, Mattes R (2015) The role of protein in weight loss and maintenance. Am J Clin Nutr 101(6):1320S-1329S. 10.3945/ajcn.114.084038 [DOI] [PubMed] [Google Scholar]
- 5.Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Kostenberger M, Tmava Berisha A, Martucci G, Pilz S, Malle O (2020) Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr 74(11):1498–1513. 10.1038/s41430-020-0558-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kumar A, Nirmal P, Kumar M, Jose A, Tomer V, Oz E, Proestos C, Zeng M, Elobeid T, Sneha K, Oz F (2023) Major phytochemicals: recent advances in health benefits and extraction method. Molecules 28(2):887-927 [DOI] [PMC free article] [PubMed]
- 7.Jacquier EF, Kassis A, Marcu D, Contractor N, Hong J, Hu C, Kuehn M, Lenderink C, Rajgopal A (2024) Phytonutrients in the promotion of healthspan: a new perspective. Front Nutr 11:1409339. 10.3389/fnut.2024.1409339 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.WHO (2025) Health Promotion. WHO. https://www.who.int/westernpacific/about/how-we-work/programmes/health-promotion
- 9.TEAM WHO (2020) Healthy ageing and functional ability. WHO. https://www.who.int/news-room/questions-and-answers/item/healthy-ageing-and-functional-ability.
- 10.Brown L, Cohen B, Costello R, Brazhnik O, Galis Z (2023) Conceptualizing a resilience research framework at the National Institutes of Health. Stress Health 39(S1):4–9. 10.1002/smi.3260 [DOI] [PubMed] [Google Scholar]
- 11.Cesari M, Araujo de Carvalho I, Amuthavalli Thiyagarajan J, Cooper C, Martin FC, Reginster JY, Vellas B, Beard JR (2018) Evidence for the domains supporting the construct of intrinsic capacity. J Gerontol A Biol Sci Med Sci 73(12):1653–1660. 10.1093/gerona/gly011 [DOI] [PubMed] [Google Scholar]
- 12.Stroeve JHM, van Wietmarschen H, Kremer BHA, van Ommen B, Wopereis S (2015) Phenotypic flexibility as a measure of health: the optimal nutritional stress response test. Genes Nutr 10(3):13. 10.1007/s12263-015-0459-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Covarrubias AJ, Perrone R, Grozio A, Verdin E (2021) NAD(+) metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol 22(2):119–141. 10.1038/s41580-020-00313-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.McReynolds MR, Chellappa K, Chiles E, Jankowski C, Shen Y, Chen L, Descamps HC, Mukherjee S, Bhat YR, Lingala SR, Chu Q, Botolin P, Hayat F, Doke T, Susztak K, Thaiss CA, Lu W, Migaud ME, Su X, Rabinowitz JD, Baur JA (2021) NAD(+) flux is maintained in aged mice despite lower tissue concentrations. Cell Syst 12(12):1160-1172 e1164. 10.1016/j.cels.2021.09.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.de Guia RM, Agerholm M, Nielsen TS, Consitt LA, Sogaard D, Helge JW, Larsen S, Brandauer J, Houmard JA, Treebak JT (2019) Aerobic and resistance exercise training reverses age-dependent decline in NAD(+) salvage capacity in human skeletal muscle. Physiol Rep 7(12):e14139. 10.14814/phy2.14139 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Sharma A, Chabloz S, Lapides RA, Roider E, Ewald CY (2023) Potential synergistic supplementation of NAD+ promoting compounds as a strategy for increasing healthspan. Nutrients. 10.3390/nu15020445 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Elhassan YS, Kluckova K, Fletcher RS, Schmidt MS, Garten A, Doig CL, Cartwright DM, Oakey L, Burley CV, Jenkinson N, Wilson M, Lucas SJE, Akerman I, Seabright A, Lai YC, Tennant DA, Nightingale P, Wallis GA, Manolopoulos KN, Brenner C, Philp A, Lavery GG (2019) Nicotinamide riboside augments the aged human skeletal muscle NAD(+) metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Rep 28(7):1717–1728. 10.1016/j.celrep.2019.07.043 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Zhou B, Wang DD, Qiu Y, Airhart S, Liu Y, Stempien-Otero A, O’Brien KD, Tian R (2020) Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure. J Clin Invest 130(11):6054–6063. 10.1172/JCI138538 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Remie CME, Roumans KHM, Moonen MPB, Connell NJ, Havekes B, Mevenkamp J, Lindeboom L, de Wit VHW, van de Weijer T, Aarts S, Lutgens E, Schomakers BV, Elfrink HL, Zapata-Perez R, Houtkooper RH, Auwerx J, Hoeks J, Schrauwen-Hinderling VB, Phielix E, Schrauwen P (2020) Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. Am J Clin Nutr 112(2):413–426. 10.1093/ajcn/nqaa072 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Wang DD, Airhart SE, Zhou B, Shireman LM, Jiang S, Melendez Rodriguez C, Kirkpatrick JN, Shen DD, Tian R, O’Brien KD (2022) Safety and tolerability of nicotinamide riboside in heart failure with reduced ejection fraction. JACC Basic Transl Sci 7(12):1183–1196. 10.1016/j.jacbts.2022.06.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Han K, Singh K, Meadows AM, Sharma R, Hassanzadeh S, Wu J, Goss-Holmes H, Huffstutler RD, Teague HL, Mehta NN, Griffin JL, Tian R, Traba J, Sack MN (2023) Boosting NAD preferentially blunts Th17 inflammation via arginine biosynthesis and redox control in healthy and psoriasis subjects. Cell Rep Med 4(9):101157. 10.1016/j.xcrm.2023.101157 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Brakedal B, Dolle C, Riemer F, Ma Y, Nido GS, Skeie GO, Craven AR, Schwarzlmuller T, Brekke N, Diab J, Sverkeli L, Skjeie V, Varhaug K, Tysnes OB, Peng S, Haugarvoll K, Ziegler M, Gruner R, Eidelberg D, Tzoulis C (2022) The NADPARK study: a randomized phase i trial of nicotinamide riboside supplementation in Parkinson’s disease. Cell Metab 34(3):396–407. 10.1016/j.cmet.2022.02.001 [DOI] [PubMed] [Google Scholar]
- 23.Bernstein PS, Li B, Vachali PP, Gorusupudi A, Shyam R, Henriksen BS, Nolan JM (2016) Lutein, zeaxanthin, and meso-zeaxanthin: the basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease. Prog Retin Eye Res 50:34–66. 10.1016/j.preteyeres.2015.10.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Ma L, Lin XM, Zou ZY, Xu XR, Li Y, Xu R (2009) A 12-week lutein supplementation improves visual function in Chinese people with long-term computer display light exposure. Br J Nutr 102(2):186–190. 10.1017/S0007114508163000 [DOI] [PubMed] [Google Scholar]
- 25.Matthews JJ, Artioli GG, Turner MD, Sale C (2019) The physiological roles of carnosine and beta-alanine in exercising human skeletal muscle. Med Sci Sports Exerc 51(10):2098–2108. 10.1249/MSS.0000000000002033 [DOI] [PubMed] [Google Scholar]
- 26.Varanoske AN, Wells AJ, Kozlowski GJ, Gepner Y, Frosti CL, Boffey D, Coker NA, Harat I, Hoffman JR (2018) <article-title update="added">Effects of β-alanine supplementation on physical performance, cognition, endocrine function, and inflammation during a 24 h simulated military operation. Physiol Rep 6(24):e13938. 10.14814/phy2.13938 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Hansen AL, Ambroziak G, Thornton D, Mundt JC, Kahn RE, Dahl L, Waage L, Kattenbraker D, Araujo P, Murison R, Rypdal K, Grung B (2020) Vitamin D supplementation during winter: effects on stress resilience in a randomized control trial. Nutrients. 10.3390/nu12113258 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.IADSA. https://www.iadsa.org/
- 29.CRN. 2023 consumer survey on dietary supplements. https://www.crnusa.org/2023survey
- 30.Liu L, Tao H, Xu J, Liu L, Nahata MC (2024) Quantity, duration, adherence, and reasons for dietary supplement use among adults: results from NHANES 2011-2018. Nutrients. 10.3390/nu16121830 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Bryan C (1964) Ancient Egyptian Medicine: The Papyrus Ebers. Ares Publishers.
- 32.Sarkar D, Walker-Swaney J, Shetty K (2020) Food diversity and indigenous food systems to combat diet-linked chronic diseases. Curr Dev Nutr 4(Suppl 1):3–11. 10.1093/cdn/nzz099 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Verrill A (1937) Foods America Gave the World. LC Page & Company
- 34.Park S, Hongu N, Daily J (2016) Native American foods: history, culture, and influence on modern diets. J Ethnic Foods 2016(3):171–177. 10.1016/j.jef.2016.08.001 [Google Scholar]
- 35.LaDuke W, Alexander S (2004) Food is medicine: recovering traditional foods to heal the people
- 36.Payyappallimana U, Venkatasubramanian P (2016) Exploring ayurvedic knowledge on food and health for providing innovative solutions to contemporary healthcare. Front Public Health 4:57. 10.3389/fpubh.2016.00057 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Sarkar P, Kumar L, Dhumal C, Panigrahi S (2015) Traditional and ayurvedic foods of Indian origin. H Ethn Foods 2:97–109. 10.1016/j.jef.2015.08.003 [Google Scholar]
- 38.Lloyd G ed (1984) Hippocratic writings. Penguin Classics
- 39.Precope J (1952) Hippocrates on diet and hygiene. vol London, England. Williams, Lea & Co.
- 40.Wu Q, Liang X (2018) Food therapy and medical diet therapy of traditional Chinese medicine. Clin Nutr Exp 18:1–5 [Google Scholar]
- 41.UN DoEaSA (2023) Leaving no one behind in an ageing world: world social report 2023. https://www.un.org/development/desa/dspd/wp-content/uploads/sites/22/2023/01/2023wsr-chapter1-.pdf
- 42.Garmany A, Yamada S, Terzic A (2021) Longevity leap: mind the healthspan gap. NPJ Regen Med 6(1):57. 10.1038/s41536-021-00169-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Volpp KG, Berkowitz SA, Sharma SV, Anderson CAM, Brewer LC, Elkind MSV, Gardner CD, Gervis JE, Harrington RA, Herrero M, Lichtenstein AH, McClellan M, Muse J, Roberto CA, Zachariah JPV, American Heart Association (2023) Food is medicine: a presidential advisory from the American Heart Association. Circulation 148(18):1417–1439. 10.1161/CIR.0000000000001182 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Mozaffarian D, Aspry KE, Garfield K, Kris-Etherton P, Seligman H, Velarde GP, Williams K, Yang E, Nutrition ACCPoCDS, Lifestyle Working G, Disparities of Care Working G (2024) “Food is medicine” strategies for nutrition security and cardiometabolic health equity: JACC state-of-the-art review. J Am Coll Cardiol 83(8):843–864. 10.1016/j.jacc.2023.12.023 [DOI] [PubMed] [Google Scholar]
- 45.Joshi K, Smith S, Bolen SD, Osborne A, Benko M, Trapl ES (2019) Implementing a produce prescription program for hypertensive patients in safety net clinics. Health Promot Pract 20(1):94–104. 10.1177/1524839917754090 [DOI] [PubMed] [Google Scholar]
- 46.Trapl ES, Joshi K, Taggart M, Patrick A, Meschkat E, Freedman D (2017) Mixed methods evaluation of a produce prescription program for pregnant women. J Hunger Environ Nutr 12(4):529–543 [Google Scholar]
- 47.Newman T, Lee JS (2021) Strategies and challenges: qualitative lessons learned from Georgia produce prescription programs. Health Promot Pract 23(4):699–707. 10.1177/15248399211028558 [DOI] [PubMed] [Google Scholar]
- 48.Stotz S, Nugent N, Ridberg R et al (2022) Produce prescription projects: challenges, solutions, and emerging best practices—perspectives from health care providers. Prev Med Rep 29:101951. 10.1016/j.pmedr.2022.101951 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Folta SC, Li Z, Cash SB, Hager K, Zhang FF (2023) Adoption and implementation of produce prescription programs for under-resourced populations: clinic staff perspectives. Front Nutr 10:1221785. 10.3389/fnut.2023.1221785 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Houghtaling B, Short E, Shanks CB, Stotz SA, Yaroch A, Seligman H, Marriott JP, Eastman J, Long CR (2024) Implementation of food is medicine programs in healthcare settings: a narrative review. J Gen Intern Med 39(14):2797–2805. 10.1007/s11606-024-08768-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Moore DR (2014) Keeping older muscle “young” through dietary protein and physical activity. Adv Nutr 5(5):599S-607S. 10.3945/an.113.005405 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Houston DK, Nicklas BJ, Ding J, Harris TB, Tylavsky FA, Newman AB, Lee JS, Sahyoun NR, Visser M, Kritchevsky SB (2008) Dietary protein intake is associated with lean mass change in older, community-dwelling adults: the Health, Aging, and Body Composition (Health ABC) study. Am J Clin Nutr 87(1):150–155. 10.1093/ajcn/87.1.150 [DOI] [PubMed] [Google Scholar]
- 53.Campbell WW, Trappe TA, Wolfe RR, Evans WJ (2001) The recommended dietary allowance for protein may not be adequate for older people to maintain skeletal muscle. J Gerontol A Biol Sci Med Sci 56(6):M373-380. 10.1093/gerona/56.6.m373 [DOI] [PubMed] [Google Scholar]
- 54.Melton LJ, Khosla S, Crowson CS, O’Connor MK, O’Fallon WM, Riggs BL (2000) Epidemiology of sarcopenia. J Am Geriatr Soc 48(6):625–630 [PubMed] [Google Scholar]
- 55.Lemieux FC, Filion ME, Barbat-Artigas S, Karelis AD, Aubertin-Leheudre M (2014) Relationship between different protein intake recommendations with muscle mass and muscle strength. Climacteric 17(3):294–300. 10.3109/13697137.2013.829440 [DOI] [PubMed] [Google Scholar]
- 56.Suga H, Hashimoto H (2018) Age threshold for recommending higher protein intake to prevent age-related muscle weakness: a cross-sectional study in Japan. PLoS ONE 13(12):e0208169. 10.1371/journal.pone.0208169 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, Phillips S, Sieber C, Stehle P, Teta D, Visvanathan R, Volpi E, Boirie Y (2013) Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE study group. J Am Med Dir Assoc 14(8):542–559. 10.1016/j.jamda.2013.05.021 [DOI] [PubMed] [Google Scholar]
- 58.Volpi E, Campbell WW, Dwyer JT, Johnson MA, Jensen GL, Morley JE, Wolfe RR (2013) Is the optimal level of protein intake for older adults greater than the recommended dietary allowance? J Gerontol A Biol Sci Med Sci 68(6):677–681. 10.1093/gerona/gls229 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Phillips SM, Chevalier S, Leidy HJ (2016) Protein “requirements” beyond the RDA: implications for optimizing health. Appl Physiol Nutr Metab 41(5):565–572. 10.1139/apnm-2015-0550 [DOI] [PubMed] [Google Scholar]
- 60.Koopmans L, van Oppenraaij S, Heijmans MWF, Verlaan S, Schoufour JD, Ten Haaf DSM, van der Avoort CMT, van den Helder J, Memelink R, Verreijen A, Weijs PJM, Eijsvogels TMH, Hopman MTE (2025) Dietary protein intake, protein sources & distribution patterns in community-dwelling older adults: a harmonized analysis of eight studies. Clin Nutr 47:177–184. 10.1016/j.clnu.2025.02.022 [DOI] [PubMed] [Google Scholar]
- 61.Shad BJ, Thompson JL, Breen L (2016) Does the muscle protein synthetic response to exercise and amino acid-based nutrition diminish with advancing age? A systematic review. Am J Physiol Endocrinol Metab 311(5):E803–E817. 10.1152/ajpendo.00213.2016 [DOI] [PubMed] [Google Scholar]
- 62.Moore DR, Churchward-Venne TA, Witard O, Breen L, Burd NA, Tipton KD, Phillips SM (2015) Protein ingestion to stimulate myofibrillar protein synthesis requires greater relative protein intakes in healthy older versus younger men. J Gerontol A Biol Sci Med Sci 70(1):57–62. 10.1093/gerona/glu103 [DOI] [PubMed] [Google Scholar]
- 63.Gao Q, Mei F, Shang Y, Hu K, Chen F, Zhao L, Ma B (2021) Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis. Clin Nutr 40(7):4633–4641. 10.1016/j.clnu.2021.06.009 [DOI] [PubMed] [Google Scholar]
- 64.Beals JW, Burd NA, Moore DR, van Vliet S (2019) Obesity alters the muscle protein synthetic response to nutrition and exercise. Front Nutr 6:87. 10.3389/fnut.2019.00087 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Smeuninx B, McKendry J, Wilson D, Martin U, Breen L (2017) Age-related anabolic resistance of myofibrillar protein synthesis is exacerbated in obese inactive individuals. J Clin Endocrinol Metab 102(9):3535–3545. 10.1210/jc.2017-00869 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Tieland M, den Borgonjen-Van Berg KJ, van Loon LJ, de Groot LC (2012) Dietary protein intake in community-dwelling, frail, and institutionalized elderly people: scope for improvement. Eur J Nutr 51(2):173–179. 10.1007/s00394-011-0203-6 [DOI] [PubMed] [Google Scholar]
- 67.Morgan PT, Harris DO, Marshall RN, Quinlan JI, Edwards SJ, Allen SL, Breen L (2021) Protein source and quality for skeletal muscle anabolism in young and older adults: a systematic review and meta-analysis. J Nutr 151(7):1901–1920. 10.1093/jn/nxab055 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR (2006) A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am J Physiol Endocrinol Metab 291(2):E381-387. 10.1152/ajpendo.00488.2005 [DOI] [PubMed] [Google Scholar]
- 69.Devries MC, McGlory C, Bolster DR, Kamil A, Rahn M, Harkness L, Baker SK, Phillips SM (2018) Leucine, not total protein, content of a supplement is the primary determinant of muscle protein anabolic responses in healthy older women. J Nutr 148(7):1088–1095. 10.1093/jn/nxy091 [DOI] [PubMed] [Google Scholar]
- 70.Devries MC, McGlory C, Bolster DR, Kamil A, Rahn M, Harkness L, Baker SK, Phillips SM (2018) Protein leucine content is a determinant of shorter- and longer-term muscle protein synthetic responses at rest and following resistance exercise in healthy older women: a randomized, controlled trial. Am J Clin Nutr 107(2):217–226. 10.1093/ajcn/nqx028 [DOI] [PubMed] [Google Scholar]
- 71.Murphy CH, Saddler NI, Devries MC, McGlory C, Baker SK, Phillips SM (2016) Leucine supplementation enhances integrative myofibrillar protein synthesis in free-living older men consuming lower- and higher-protein diets: a parallel-group crossover study. Am J Clin Nutr 104(6):1594–1606. 10.3945/ajcn.116.136424 [DOI] [PubMed] [Google Scholar]
- 72.Matthews JJ, Arentson-Lantz EJ, Moughan PJ, Wolfe RR, Ferrando AA, Church DD (2025) Understanding dietary protein quality: digestible indispensable amino acid scores and beyond. J Nutr 155(10):3152–3167. 10.1016/j.tjnut.2025.07.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Levine ME, Suarez JA, Brandhorst S, Balasubramanian P, Cheng CW, Madia F, Fontana L, Mirisola MG, Guevara-Aguirre J, Wan J, Passarino G, Kennedy BK, Wei M, Cohen P, Crimmins EM, Longo VD (2014) Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metab 19(3):407–417. 10.1016/j.cmet.2014.02.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Chen Z, Glisic M, Song M, Aliahmad HA, Zhang X, Moumdjian AC, Gonzalez-Jaramillo V, van der Schaft N, Bramer WM, Ikram MA, Voortman T (2020) Dietary protein intake and all-cause and cause-specific mortality: results from the Rotterdam Study and a meta-analysis of prospective cohort studies. Eur J Epidemiol 35(5):411–429. 10.1007/s10654-020-00607-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Papanikolaou Y, Phillips SM, Fulgoni VL 3rd (2025) Animal and plant protein usual intakes are not adversely associated with all-cause, cardiovascular disease-, or cancer-related mortality risk: an NHANES III analysis. Appl Physiol Nutr Metab 50(1):1–8. 10.1139/apnm-2023-0594 [DOI] [PubMed] [Google Scholar]
- 76.Ding D, Van Buskirk J, Nguyen B, Stamatakis E, Elbarbary M, Veronese N, Lee I-M, Ekelund U, Fontana L (2022) Physical activity, diet quality and all-cause cardiovascular disease and cancer mortality: a prospective study of 346 627 UK Biobank participants. Br J Sports Med. 10.1136/bjsports-2021-105195 [DOI] [PubMed] [Google Scholar]
- 77.Oikawa SY, Holloway TM, Phillips SM (2019) The impact of step reduction on muscle health in aging: protein and exercise as countermeasures. Front Nutr 6:75. 10.3389/fnut.2019.00075 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Breen L, Stokes KA, Churchward-Venne TA, Moore DR, Baker SK, Smith K, Atherton PJ, Phillips SM (2013) Two weeks of reduced activity decreases leg lean mass and induces “anabolic resistance” of myofibrillar protein synthesis in healthy elderly. J Clin Endocrinol Metab 98(6):2604–2612. 10.1210/jc.2013-1502 [DOI] [PubMed] [Google Scholar]
- 79.Burd NA, Gorissen SH, van Loon LJ (2013) Anabolic resistance of muscle protein synthesis with aging. Exerc Sport Sci Rev 41(3):169–173. 10.1097/JES.0b013e318292f3d5 [DOI] [PubMed] [Google Scholar]
- 80.Bassett DR Jr., Wyatt HR, Thompson H, Peters JC, Hill JO (2010) Pedometer-measured physical activity and health behaviors in U.S. adults. Med Sci Sports Exerc 42(10):1819–1825. 10.1249/MSS.0b013e3181dc2e54 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Shephard RJ, Park H, Park S, Aoyagi Y (2013) Objectively measured physical activity and progressive loss of lean tissue in older Japanese adults: longitudinal data from the Nakanojo study. J Am Geriatr Soc 61(11):1887–1893. 10.1111/jgs.12505 [DOI] [PubMed] [Google Scholar]
- 82.Petrella JK, Cress ME (2004) Daily ambulation activity and task performance in community-dwelling older adults aged 63–71 years with preclinical disability. J Gerontol A Biol Sci Med Sci 59(3):264–267. 10.1093/gerona/59.3.m264 [DOI] [PubMed] [Google Scholar]
- 83.Devries MC, Breen L, Von Allmen M, MacDonald MJ, Moore DR, Offord EA, Horcajada MN, Breuille D, Phillips SM (2015) Low-load resistance training during step-reduction attenuates declines in muscle mass and strength and enhances anabolic sensitivity in older men. Physiol Rep. 10.14814/phy2.12493 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Pennings B, Koopman R, Beelen M, Senden JM, Saris WH, van Loon LJ (2011) Exercising before protein intake allows for greater use of dietary protein-derived amino acids for de novo muscle protein synthesis in both young and elderly men. Am J Clin Nutr 93(2):322–331. 10.3945/ajcn.2010.29649 [DOI] [PubMed] [Google Scholar]
- 85.Fujita S, Rasmussen BB, Cadenas JG, Drummond MJ, Glynn EL, Sattler FR, Volpi E (2007) Aerobic exercise overcomes the age-related insulin resistance of muscle protein metabolism by improving endothelial function and Akt/mammalian target of rapamycin signaling. Diabetes 56(6):1615–1622. 10.2337/db06-1566 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Timmerman KL, Dhanani S, Glynn EL, Fry CS, Drummond MJ, Jennings K, Rasmussen BB, Volpi E (2012) A moderate acute increase in physical activity enhances nutritive flow and the muscle protein anabolic response to mixed nutrient intake in older adults. Am J Clin Nutr 95(6):1403–1412. 10.3945/ajcn.111.020800 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Moore DR, Williamson EP, Hodson N, Estafanos S, Mazzulla M, Kumbhare D, Gillen JB (2022) Walking or body weight squat “activity snacks” increase dietary amino acid utilization for myofibrillar protein synthesis during prolonged sitting. J Appl Physiol 133(3):777–785. 10.1152/japplphysiol.00106.2022 [DOI] [PubMed] [Google Scholar]
- 88.Frank J, Fukagawa NK, Bilia AR, Johnson EJ, Kwon O, Prakash V, Miyazawa T, Clifford MN, Kay CD, Crozier A, Erdman JW, Shao A, Williamson G (2020) Terms and nomenclature used for plant-derived components in nutrition and related research: efforts toward harmonization. Nutr Rev 78(6):451–458. 10.1093/nutrit/nuz081 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Arfaoui L (2021) Dietary plant polyphenols: effects of food processing on their content and bioavailability. Molecules. 10.3390/molecules26102959 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Pagliai G, Dinu M, Madarena MP, Bonaccio M, Iacoviello L, Sofi F (2021) Consumption of ultra-processed foods and health status: a systematic review and meta-analysis. Br J Nutr 125(3):308–318. 10.1017/S0007114520002688 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Sies H (2007) Total antioxidant capacity: appraisal of a concept. J Nutr 137(6):1493–1495. 10.1093/jn/137.6.1493 [DOI] [PubMed] [Google Scholar]
- 92.Visvanathan R, Houghton MJ, Barber E, Williamson G (2024) Structure-function relationships in (poly)phenol-enzyme binding: direct inhibition of human salivary and pancreatic alpha-amylases. Food Res Int 188:114504 [DOI] [PubMed] [Google Scholar]
- 93.Farazi M, Houghton MJ, Murray M, Williamson G (2023) A systematic review of the inhibitory effect of extracts from edible parts of nuts on alpha-glucosidase activity. Food Funct 14(13):5962–5976. 10.1039/d3fo00328k [DOI] [PubMed] [Google Scholar]
- 94.Hanefeld M, Schaper F, Koehler C (2008) Effect of acarbose on vascular disease in patients with abnormal glucose tolerance. Cardiovasc Drugs Ther 22(3):225–231. 10.1007/s10557-008-6091-1 [DOI] [PubMed] [Google Scholar]
- 95.Ponce O, Benassi R, Cesar T (2019) Orange juice associated with a balanced diet mitigated risk factors of metabolic syndrome: a randomized controlled trial. J Nutr Intermed Metab. 10.1016/j.jnim.2019.100101 [Google Scholar]
- 96.Ribeiro C, Dourado G, Cesar S (2017) Orange juice allied to a reduced-calorie diet results in weight loss and ameliorates obesity-related biomarkers: a randomized controlled trial. Nutrition 38:13–19. 10.1016/j.nut.2016.12.020 [DOI] [PubMed] [Google Scholar]
- 97.Simpson EJ, Mendis B, Macdonald IA (2016) Orange juice consumption and its effect on blood lipid profile and indices of the metabolic syndrome; a randomised, controlled trial in an at-risk population. Food Funct 7(4):1884–1891. 10.1039/c6fo00039h [DOI] [PubMed] [Google Scholar]
- 98.Yari Z, Movahedian M, Imani H, Alavian SM, Hedayati M, Hekmatdoost A (2020) The effect of hesperidin supplementation on metabolic profiles in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial. Eur J Nutr 59(6):2569–2577. 10.1007/s00394-019-02105-2 [DOI] [PubMed] [Google Scholar]
- 99.Ding M, Bhupathiraju SN, Chen M, van Dam RM, Hu FB (2014) Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care 37(2):569–586. 10.2337/dc13-1203 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Yang J, Mao QX, Xu HX, Ma X, Zeng CY (2014) Tea consumption and risk of type 2 diabetes mellitus: a systematic review and meta-analysis update. BMJ Open 4(7):e005632. 10.1136/bmjopen-2014-005632 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Yang WS, Wang WY, Fan WY, Deng Q, Wang X (2014) Tea consumption and risk of type 2 diabetes: a dose-response meta-analysis of cohort studies. Br J Nutr 111(8):1329–1339. 10.1017/S0007114513003887 [DOI] [PubMed] [Google Scholar]
- 102.Bhupathiraju SN, Pan A, Malik VS, Manson JE, Willett WC, van Dam RM, Hu FB (2013) Caffeinated and caffeine-free beverages and risk of type 2 diabetes. Am J Clin Nutr 97(1):155–166. 10.3945/ajcn.112.048603 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Greenberg JA, Boozer CN, Geliebter A (2006) Coffee, diabetes, and weight control. Am J Clin Nutr 84(4):682–693. 10.1093/ajcn/84.4.682 [DOI] [PubMed] [Google Scholar]
- 104.van Dam RM, Hu FB (2005) Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 294(1):97–104. 10.1001/jama.294.1.97 [DOI] [PubMed] [Google Scholar]
- 105.Huxley R, Lee CM, Barzi F, Timmermeister L, Czernichow S, Perkovic V, Grobbee DE, Batty D, Woodward M (2009) Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med 169(22):2053–2063. 10.1001/archinternmed.2009.439 [DOI] [PubMed] [Google Scholar]
- 106.Fairlie-Jones L, Davison K, Fromentin E, Hill AM (2017) The effect of anthocyanin-rich foods or extracts on vascular function in adults: a systematic review and meta-analysis of randomised controlled trials. Nutrients. 10.3390/nu9080908 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Sesso HD, Manson JE, Aragaki AK, Rist PM, Johnson LG, Friedenberg G, Copeland T, Clar A, Mora S, Moorthy MV, Sarkissian A, Carrick WR, Anderson GL, Group CR (2022) Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial. Am J Clin Nutr 115(6):1490–1500. 10.1093/ajcn/nqac055 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.van Schoor NM, Lips P (2011) Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab 25(4):671–680. 10.1016/j.beem.2011.06.007 [DOI] [PubMed] [Google Scholar]
- 109.Bischoff-Ferrari HA, Can U, Staehelin HB, Platz A, Henschkowski J, Michel BA, Dawson-Hughes B, Theiler R (2008) Severe vitamin D deficiency in Swiss hip fracture patients. Bone 42(3):597–602. 10.1016/j.bone.2007.10.026 [DOI] [PubMed] [Google Scholar]
- 110.MacLaughlin J, Holick MF (1985) Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 76(4):1536–1538. 10.1172/JCI112134 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29(6):726–776. 10.1210/er.2008-0004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Holick MF (2024) Vitamin D and bone health: what vitamin D can and cannot do. Adv Food Nutr Res 109:43–66. 10.1016/bs.afnr.2024.04.002 [DOI] [PubMed] [Google Scholar]
- 113.Bischoff-Ferrari HA, Borchers M, Gudat F, Durmuller U, Stahelin HB, Dick W (2004) Vitamin d receptor expression in human muscle tissue decreases with age. J Bone Miner Res 19(2):265–269. 10.1359/jbmr.2004.19.2.265 [DOI] [PubMed] [Google Scholar]
- 114.Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J (2009) Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 339:b3692. 10.1136/bmj.b3692 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, Flicker L, Wark J, Jackson RD, Cauley JA, Meyer HE, Pfeifer M, Sanders KM, Stahelin HB, Theiler R, Dawson-Hughes B (2012) A pooled analysis of vitamin d dose requirements for fracture prevention. N Engl J Med 367(1):40–49. 10.1056/NEJMoa1109617 [DOI] [PubMed] [Google Scholar]
- 116.LeBoff MS, Bischoff-Ferrari HA (2023) The effects of vitamin D supplementation on musculoskeletal health: the VITAL and DO-Health Trials. J Gerontol A Biol Sci Med Sci 78(Suppl 1):73–78. 10.1093/gerona/glad073 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.LeBoff MS, Murata EM, Cook NR, Cawthon P, Chou SH, Kotler G, Bubes V, Buring JE, Manson JE (2020) VITamin D and OmegA-3 TriaL (VITAL): effects of vitamin D supplements on risk of falls in the US population. J Clin Endocrinol Metab 105(9):2929–2938. 10.1210/clinem/dgaa311 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Bischoff-Ferrari HA, Vellas B, Rizzoli R, Kressig RW, da Silva JAP, Blauth M, Felson DT, McCloskey EV, Watzl B, Hofbauer LC, Felsenberg D, Willett WC, Dawson-Hughes B, Manson JE, Siebert U, Theiler R, Staehelin HB, de Godoi Rezen Costa Molino C, Chocano-Bedoya PO, Abderhalden LA, Egli A, Kanis JA, Orav EJ, Group D-HR (2020) Effect of vitamin D supplementation, omega-3 fatty acid supplementation, or a strength-training exercise program on clinical outcomes in older adults: the DO-HEALTH randomized clinical trial. JAMA 324(18):1855–1868. 10.1001/jama.2020.16909 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Mazess RB, Bischoff-Ferrari HA, Dawson-Hughes B (2021) Vitamin D: bolus is bogus-a narrative review. JBMR Plus 5(12):e10567. 10.1002/jbm4.10567 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, Gibson H, Gordon D, Copeland T, D’Agostino D, Friedenberg G, Ridge C, Bubes V, Giovannucci EL, Willett WC, Buring JE, Group V (2019) Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med 380(1):33–44. 10.1056/NEJMoa1809944 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Dong Y, Zhu H, Chen L, Huang Y, Christen W, Cook NR, Copeland T, Mora S, Buring JE, Lee IM, Costenbader KH, Manson JE (2022) Effects of vitamin D(3) and marine omega-3 fatty acids supplementation on biomarkers of systemic inflammation: 4-year findings from the VITAL randomized trial. Nutrients. 10.3390/nu14245307 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Hahn J, Cook NR, Alexander EK, Friedman S, Walter J, Bubes V, Kotler G, Lee IM, Manson JE, Costenbader KH (2022) Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ 376:e066452. 10.1136/bmj-2021-066452 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Chandler PD, Chen WY, Ajala ON, Hazra A, Cook N, Bubes V, Lee IM, Giovannucci EL, Willett W, Buring JE, Manson JE (2020) Effect of Vitamin D3 supplements on development of advanced cancer: a secondary analysis of the VITAL randomized clinical trial. JAMA Netw Open 3(11):e2025850. 10.1001/jamanetworkopen.2020.25850 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Bischoff-Ferrari HA, Willett WC, Manson JE, Dawson-Hughes B, Manz MG, Theiler R, Braendle K, Vellas B, Rizzoli R, Kressig RW, Staehelin HB, Da Silva JAP, Armbrecht G, Egli A, Kanis JA, Orav EJ, Gaengler S (2022) Combined vitamin d, omega-3 fatty acids, and a simple home exercise program may reduce cancer risk among active adults aged 70 and older: a randomized clinical trial. Front Aging 3:852643. 10.3389/fragi.2022.852643 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125.Gagesch M, Wieczorek M, Vellas B, Kressig RW, Rizzoli R, Kanis J, Willett WC, Egli A, Lang W, Orav EJ, Bischoff-Ferrari HA (2023) Effects of vitamin D, omega-3 fatty acids and a home exercise program on prevention of pre-frailty in older adults: the DO-HEALTH randomized clinical trial. J Frailty Aging 12(1):71–77. 10.14283/jfa.2022.48 [DOI] [PubMed] [Google Scholar]
- 126.Bischoff-Ferrari HA, Gangler S, Wieczorek M, Belsky DW, Ryan J, Kressig RW, Stahelin HB, Theiler R, Dawson-Hughes B, Rizzoli R, Vellas B, Rouch L, Guyonnet S, Egli A, Orav EJ, Willett W, Horvath S (2025) Individual and additive effects of vitamin d, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial. Nat Aging 5(3):376–385. 10.1038/s43587-024-00793-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 127.Somogyi A, Hathcock J, Biesalski HK, Blumberg JB, Antoine JM, Edwards G, Prock P (2011) Scientific issues related to Codex Alimentarius goals: a review of principles, with examples. Regul Toxicol Pharmacol 60(1):161–164. 10.1016/j.yrtph.2011.02.011 [DOI] [PubMed] [Google Scholar]
- 128.Aggett PJ, Hathcock J, Jukes D, Richardson DP, Calder PC, Bischoff-Ferrari H, Nicklas T, Muhlebach S, Kwon O, Lewis J, Lugard MJ, Prock P (2012) Nutrition issues in Codex: health claims, nutrient reference values and WTO agreements: a conference report. Eur J Nutr 51(1):S1-7. 10.1007/s00394-012-0306-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129.Biesalski HK, Erdman JW Jr., Hathcock J, Ellwood K, Beatty S, Johnson E, Marchioli R, Lauritzen L, Rice HB, Shao A, Griffiths JC (2013) Nutrient reference values for bioactives: new approaches needed? A conference report. Eur J Nutr 52(1):1–9. 10.1007/s00394-013-0503-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.Lupton JR, Atkinson SA, Chang N, Fraga CG, Levy J, Messina M, Richardson DP, van Ommen B, Yang Y, Griffiths JC, Hathcock J (2014) Exploring the benefits and challenges of establishing a DRI-like process for bioactives. Eur J Nutr 53(1):1–9. 10.1007/s00394-014-0666-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131.LeDoux MA, Appelhans KR, Braun LA, Dziedziczak D, Jennings S, Liu L, Osiecki H, Wyszumiala E, Griffiths JC (2015) A quality dietary supplement: before you start and after it’s marketed--a conference report. Eur J Nutr 54(Suppl 1):S1-8. 10.1007/s00394-014-0827-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132.Lupton JR, Blumberg JB, L’Abbe M, LeDoux M, Rice HB, von Schacky C, Yaktine A, Griffiths JC (2016) Nutrient reference value: non-communicable disease endpoints--a conference report. Eur J Nutr 55(Suppl 1):S1-10. 10.1007/s00394-016-1195-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Shao A, Drewnowski A, Willcox DC, Kramer L, Lausted C, Eggersdorfer M, Mathers J, Bell JD, Randolph RK, Witkamp R, Griffiths JC (2017) Optimal nutrition and the ever-changing dietary landscape: a conference report. Eur J Nutr 56(Suppl 1):1–21. 10.1007/s00394-017-1460-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Marsman D, Belsky DW, Gregori D, Johnson MA, Low Dog T, Meydani S, Pigat S, Sadana R, Shao A, Griffiths JC (2018) Healthy ageing: the natural consequences of good nutrition-a conference report. Eur J Nutr 57(Suppl 2):15–34. 10.1007/s00394-018-1723-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135.Kalache A, de Hoogh AI, Howlett SE, Kennedy B, Eggersdorfer M, Marsman DS, Shao A, Griffiths JC (2019) Nutrition interventions for healthy ageing across the lifespan: a conference report. Eur J Nutr 58(Suppl 1):1–11. 10.1007/s00394-019-02027-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 136.Griffiths JC, De Vries J, McBurney MI, Wopereis S, Serttas S, Marsman DS (2020) Measuring health promotion: translating science into policy. Eur J Nutr 59(Suppl 2):11–23. 10.1007/s00394-020-02359-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137.Kalache A, Bazinet RP, Carlson S, Evans WJ, Kim CH, Lanham-New S, Visioli F, Griffiths JC (2021) Science-based policy: targeted nutrition for all ages and the role of bioactives. Eur J Nutr 60(Suppl 1):1–17. 10.1007/s00394-021-02662-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 138.Feskens EJM, Bailey R, Bhutta Z, Biesalski HK, Eicher-Miller H, Kramer K, Pan WH, Griffiths JC (2022) Women’s health: optimal nutrition throughout the lifecycle. Eur J Nutr 61(Suppl 1):1–23. 10.1007/s00394-022-02915-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 139.Neufeld LM, Ho E, Obeid R, Tzoulis C, Green M, Huber LG, Stout M, Griffiths JC (2023) Advancing nutrition science to meet evolving global health needs. Eur J Nutr 62(Suppl 1):1–16. 10.1007/s00394-023-03276-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
No new data were generated or analyzed in support of this symposium report. Data sharing is not applicable to this article.

